Psychemedics hires new VP of finance amid executive shakeup
Image | Courtesy of Google Maps
The Acton headquarters of Psychemedics
Psychemedics, an Acton-based manufacturer of drug testing kits, has hired Daniella Mehalik as the company’s vice president of finance, reporting directly to the CEO.
Mehalik will assume responsibility for the direction and management of all of Psychemedics financial activities, according to a Monday press release issued by the company. Mehalik will report directly to Psychemedic CEO and President Brian Hullinger in her new role.
"We are thrilled to welcome Daniella to our team, entrusting her with a critical role in the company,” Hullinger said in the press release. “Her strong technical background within the biotech sector aligns seamlessly with Psychemedics' growth strategy, positioning the company for sustained advancement.”
Mehalik replaces former vice president of finance Andrew Limbek, who left the company in August 2022 to join Marcum, a national accounting firm based in New York City, according to his LinkedIn profile.
Mehalik was most recently the vice president and controller of Neubase Therapeutics, a NASDAQ-listed biotechnology company based in Pittsburgh.
Prior to her time at Neubase, she served as the accounting controller for DxTx Medical, a medical device manufacturer also based in the Pittsburgh area, according to her LinkedIn page.
She received her undergraduate and master’s degrees in accounting from Pittsburgh-based Carlow University.
The hiring of Mehalik is the latest change of Psychemedics executive team; in addition to Limbek, SEC filings made by the company in the third fiscal quarter of 2023 showed that its vice president of lab operations, executive vice president, and assistant controller departed in September.
The company also reported a $2.1-million loss in the third quarter.
WBJ Web Partners
Most Recent
Most Recent
0 Comments